Molecular docking analysis predicts a potential interaction between CDCA3 and MYC (Fig. 6A), which was validated by Co-IP assays demonstrating an endogenous interaction in UM-UC3 and T24 BLCA cells (Fig. 6B). This evidence concerns the gene MYC and bladder transitional cell carcinoma.